8-20249796-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_021020.5(LZTS1):c.1717G>A(p.Ala573Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000229 in 1,613,876 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_021020.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LZTS1 | NM_021020.5 | c.1717G>A | p.Ala573Thr | missense_variant | 4/4 | ENST00000381569.5 | NP_066300.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LZTS1 | ENST00000381569.5 | c.1717G>A | p.Ala573Thr | missense_variant | 4/4 | 5 | NM_021020.5 | ENSP00000370981 | P1 | |
LZTS1 | ENST00000265801.6 | c.1717G>A | p.Ala573Thr | missense_variant | 3/3 | 1 | ENSP00000265801 | P1 | ||
LZTS1 | ENST00000522290.5 | c.1540G>A | p.Ala514Thr | missense_variant | 4/4 | 1 | ENSP00000429263 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152224Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000279 AC: 7AN: 251270Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135842
GnomAD4 exome AF: 0.0000219 AC: 32AN: 1461652Hom.: 0 Cov.: 31 AF XY: 0.0000124 AC XY: 9AN XY: 727148
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152224Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74372
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 18, 2021 | The c.1717G>A (p.A573T) alteration is located in exon 3 (coding exon 3) of the LZTS1 gene. This alteration results from a G to A substitution at nucleotide position 1717, causing the alanine (A) at amino acid position 573 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 26, 2023 | This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 573 of the LZTS1 protein (p.Ala573Thr). This variant is present in population databases (rs371589270, gnomAD 0.008%). This variant has not been reported in the literature in individuals affected with LZTS1-related conditions. ClinVar contains an entry for this variant (Variation ID: 2233226). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt LZTS1 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at